Winning XOMA Stock Forecast: Xoma Corporation Jumped Up By 269.14% in 1 Year

May 28, 2018

“We made significant progress on multiple fronts executing our new business strategy, and in doing so we completely transformed the Company. The highlight events were clearly the license agreements we secured for both gevokizumab and our IL-1 beta intellectual property portfolio with Novartis. Our strategy was further reinforced with new license agreements for use of our proprietary phage display libraries for antibody discovery.”

– Jim Neal, Chief Executive Officer of XOMA

[Image Source: http://www.scienceimage.csiro.au/image/2057, from Wikimedia Commons]

Over the last 12 months

Winning Stock Forecast

Amazon Stock Forecast: Amazon (NASDAQ: AMZN) Is Soundly Beating Apple In Smart Speakers

May 21, 2018

The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

AMZN Stock Forecast

Summary:

Congratulations to Amazon. It looks like Apple’s HomePod smart speaker is a flop.
As per the Q1 2018 report of Strategy Analytics, Apple only shipped out 600,000 units of the HomePod. This is way below expectations.
Amazon again topped the Q1 rankings. It shipped out 4 million Alexa-powered Echo smart speakers. This will only compel third-party developers to create more skills for Echo speakers.
Amazon touts 43.6% share of the 9.2 million (up from 2.4 million in Q1 2017) smart speakers shipped in Q1 2018.
Even if Apple produces a more affordable version of the $349 HomePod, Amazon’s long-term leadership in smart speakers will remain intact.

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Premium Articles Tech Stocks Forecast

Winning Stock Forecast: Scientific Games Corp (NASDAQ: SGMS) Is Your Lucky Bet With 124.42% In 1 Year

May 3, 2018

Winning Stock Forecast

“Our improved performance and strong future prospects enabled us to successfully refinance a portion of our capital structure in 2017 and 2018 that significantly lowers our cost of capital and increases future cash flow.” – Michael Quartieri, CFO of Scientific Games Corp

[Image Source: Officesnapshots.com]

Over the one year period from April 30, 2017 to April 30, 2018 SGMS stock price experienced steep price rise of more than 124.42%. Taking into account the overall SGMS stock performance indicators for 2017 fiscal year , it is reasonable to suggest that this is the result

AMD Stock Forecast (NASDAQ: AMD): Why AMD Is A Strong Buy Right Now

April 26, 2018

The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

FB Stock Prediction

Summary:

AMD’s stock shot up more than 9% during the after-hours trading on April 25. AMD comfortably beat the EPS and revenue estimates of Wall Street.
The Q1 2018 earnings report of AMD also revealed that its Computing and Graphics segment has posted its 5^th consecutive quarter of double digit Year-over-Year growth.
Thanks to stronger Ryzen processors sales, AMD posted an EPS of $0.11 (beats by $0.2), and revenue of $1.65 billion (+39.8% year over year) - beats by $80 million.
The reasons why AMD is beating estimates are the same. Cryptocurrency miners still bought many Radeon discrete GPUs. Ryzen APUs and processors are also finding more customers.
Do not worry about the forthcoming release of ASIC miners. They do not threaten the lucrative tailwind of AMD from Ethereum miners.

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Premium Articles Tech Stocks Forecast

Quick Win by the Algorithm: Nektar Therapeutics (NASDAQ: NKTR) Treats Investors With Stock Up 383.54% In 1 Year

March 28, 2018

Quick Algorithm

“This past year was truly transformational for Nektar as we achieved a number of successes with Nektar medicines across our three key therapeutic areas of immuno-oncology, immunology and pain”

– Howard W. Robin, President and Chief Executive Officer of Nektar Therapeutics

(Image Source: Nektar)

Over the past year Nektar Therapeutic’s stock price steadily grew from $21.60 to $104.51 per share, outperforming the market by more than 365%. So what is the driver behind that growth and what happened during 2017 financial year? The reason lies in the company’s results